Pollutants and puberty development in Guadeloupe
This study looks at how certain chemicals (called organochlorine pollutants) might affect development during puberty. It follows children born to mothers who were part of an earlier study in Guadeloupe.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were born to a mother who was in the Timoun study (from 2004 to 2007) and your parents said you could be contacted later.
- You live in Guadeloupe and are around the age of puberty (about 10 to 14 years old).
- You have health insurance coverage through the social security system.
- You and your parents agree to take part in the study and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study measures chordecone levels in people living in Guadeloupe. It tests whether a support program can help lower contamination over time.
This study looks at how exposure to chlordecone, a chemical found in some Caribbean soils, might affect a woman's ability to get pregnant. You may be asked to share your medical history and provide samples to help us understand this link.
This trial studies whether exposure to the pesticide chlordecone affects prostate cancer risk in men living in Martinique. It compares men newly diagnosed with prostate cancer to those without cancer.
This study looks at levels of chlordecone (a pesticide) in body tissues during thyroid surgery. It may help understand how this chemical affects thyroid health in Guadeloupe.
This study tests whether teaching parents about endocrine disruptors (chemicals that can affect hormones) can reduce the levels of these chemicals in newborns' urine. It aims to see if parent education can help protect babies from harmful substances.
This study looks at how genes, environment, and health history affect the growth of prostate cancer. It may help find better ways to treat the disease in people from the Caribbean and Brittany regions of France.
Hear when a new Prenatal Exposure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.